Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Indian Medtech Firms See Limited Impact From H-1B Visa Fee Hike, But R&D Collaboration Faces Risks
Industry Leaders Warn American Patients Could Pay The Price For Reduced Mobility.
Sep 30 2025
•
By
Shubham Singh
While skilled workers already in the US probably won’t lose their jobs, the move is expected to reduce future opportunities for Indians abroad and increase pressure on US institutions that rely on their services. Picture Courtesy: Shutterstock
More from Strategy
More from Business